| Condition | Key Finding | Association | Board Exam Tip |
| Diabetic Ketoacidosis (DKA) | Low {HCO}_3 (< 18 mEq/L) | Absolute insulin deficiency (Type 1 DM); Ketone bodies. | Always check the bicarbonate level to distinguish DKA from HHS. |
| Primary Adrenal Insufficiency | High ACTH, Low Cortisol, Hyperpigmentation | Lack of negative feedback on pituitary; POMC -> MSH. | The high ACTH drives the pigmentation (MSH). |
| Thyroid Storm | Fever, Tachycardia, Altered Mental Status | Hyperadrenergic state; Severe thyrotoxicosis. | Treatment is sequential: -blocker -> PTU -> SSKI -> Steroids. |
| Pituitary Apoplexy | Hypopituitarism + Visual Field Deficits | Hemorrhagic stroke/bleeding into the pituitary gland. | The visual field deficits are due to compression of the optic chiasm by bleeding. |
| Topic | Key Point | Context | Exam Relevance |
| DKA vs HHS | DKA has acidosis; HHS does not. | DKA is associated with Type 1 DM/absolute deficiency; HHS is associated with Type 2 DM/resistance. | The {HCO}_3 level is the single most important lab test to differentiate these two life-threatening states. |
| Adrenal Crisis | Primary AI = High ACTH, Low Cortisol. | Caused by adrenal gland destruction (e.g., autoimmune); high ACTH drives MSH release. | Always treat empirically with Hydrocortisone; Dexamethasone is a second-line option. |
| Thyroid Storm | Treatment must be sequential and multi-drug. | Hyperadrenergic state due to excessive thyroid hormone action. | Do not give only one drug (e.g., just PTU); the sequence matters for efficacy. |
| Hypoglycemia Workup | Sulfonylurea overdose -> Elevated Insulin + Elevated C-peptide. | Sulfonylureas block ATP-sensitive K+ channels, causing insulin release independent of glucose. | The secreted dog screen is positive in sulfonylurea overdose but negative in an insulinoma. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient presents with profound nausea/vomiting for days, has a serum bicarbonate of 12 mEq/L, and glucose of 800 mg/dL. | Diabetic Ketoacidosis (DKA) | Profound metabolic acidosis ({HCO}_3 < 18) is the hallmark distinguishing DKA from HHS. |
| A patient with known Type 2 diabetes presents with severe hyperglycemia, altered mental status, and normal serum bicarbonate levels. | Hyperglycemic Hyperosmolar State (HHS) | HHS results from profound dehydration and insulin resistance without significant ketoacid production or acidosis. |
| A woman develops hypotension, hyponatremia, hypoglycemia, and hyperkalemia after stopping her chronic steroid dose for COPD exacerbation. | Secondary Adrenal Insufficiency (Stress-induced) | Steroid withdrawal/stress can precipitate AI; the constellation of symptoms points to acute adrenal failure. |
| A patient with a history of autoimmune disease presents with low morning cortisol and high ACTH, along with hyperpigmentation. | Primary Adrenal Insufficiency (Addison's Disease) | High ACTH drives MSH release (POMC -> MSH), causing pigmentation; the pituitary is intact but the adrenal gland fails. |
| A patient presents with fever, massive tachycardia, and signs of heart failure following a thyroidectomy. | Thyroid Storm | The triad of hyperthermia, tachycardia, and altered mental status in the setting of thyrotoxicosis suggests storm. |
| A woman delivers a child and subsequently develops hypoprolactinemia, hypocortisolism, and hypothyroidism. | Sheehan Syndrome | Pituitary ischemia/necrosis following massive blood loss (hemorrhage) during delivery is the classic cause. |
| Key Features | Distinguishing Findings | Next Step |
| Primary AI: Low cortisol; High ACTH; Hyperpigmentation. | Pituitary is intact (high ACTH); Adrenal gland failure. | Treat with Glucocorticoid replacement (Hydrocortisone). |
| Secondary AI: Low cortisol; Low ACTH; No hyperpigmentation. | Problem at the pituitary level (e.g., tumor, surgery). | Determine the cause of hypocortisolism and replace glucocorticoids/mineralocorticoids as needed. |
| Key Features | Distinguishing Findings | Next Step |
| Insulinoma: Spontaneous insulin release; Insulin levels are high. | Elevated C-peptide (endogenous source). | Surgical resection of the tumor. |
| Sulfonylurea Overdose: Drug-induced insulin secretion; Insulin is high. | Elevated C-peptide AND positive secreted dog screen. | Supportive care, observation, and potentially glucagon/IV dextrose. |
| Condition | Association | Mechanism | Clinical Significance |
| DKA | Type 1 Diabetes Mellitus (Absolute Deficiency) | Lack of insulin prevents inhibition of -oxidation in the liver, leading to ketone body overproduction. | Requires immediate fluid resuscitation and potassium replacement before starting insulin. |
| Primary AI | High ACTH / Hyperpigmentation | Adrenal failure leads to lack of negative feedback on pituitary; high ACTH stimulates MSH release (from POMC). | The skin pigmentation is a key diagnostic clue pointing toward primary adrenal insufficiency. |
| Thyroid Storm | -blockers -> PTU -> SSKI -> Steroids | Sequential blockade of hyperadrenergic symptoms, T4 synthesis, and peripheral conversion ({T}_4 -> {T}_3). | The sequence is critical; starting with a -blocker prevents cardiac damage. |
| Sheehan Syndrome | Postpartum hemorrhage/Ischemia | Massive blood loss or ischemic injury to the pituitary gland during labor. | Causes pan-hypopituitarism (low prolactin, low TSH, low ACTH). |
| Term | Definition | Context | Example |
| DKA | Diabetic Ketoacidosis | A severe metabolic emergency characterized by high glucose and profound ketoacidosis. | {HCO}_3 < 18 { mEq/L} is highly suggestive of DKA. |
| HHS | Hyperglycemic Hyperosmolar State | Severe hyperglycemia with hyperosmolality, typically without significant acidosis. | Occurs in Type 2 DM patients who are severely dehydrated and insulin resistant. |
| POMC | Proopiomelanocortin | A precursor hormone cleaved into ACTH, MSH, -endorphin, etc., by the pituitary gland. | High levels of POMC metabolites (like MSH) cause skin hyperpigmentation in primary AI. |
| SSKI | Super-saturated Potassium Iodide | Used to block the peripheral conversion of T4 to T3 (Wolff-Chaikoff effect). | Administered during thyroid storm management to reduce active hormone levels. |
| Topic | Study Approach | Priority | Resources |
| Diabetic Emergencies | Focus on differentiating acidosis/bicarb status and managing K+ replacement thresholds. | High (Board-level trap question) | Review the fluid resuscitation algorithms for DKA vs HHS side-by-side. |
| Endocrine Crisis Management | Memorize sequential drug administration protocols (Thyroid Storm, Adrenal AI). | Critical (High-yield sequence recall) | Use flowcharts: -blocker first in Thyroid Storm; Hydrocortisone always used in Adrenal Crisis. |
| Pituitary Pathology | Understand the difference between ischemic vs hemorrhagic causes of pituitary failure. | Medium (Vignette recognition) | Associate specific symptoms (e.g., visual field deficits with hemorrhage/apoplexy). |